160 related articles for article (PubMed ID: 30620563)
1. Peptide Nucleic Acid-Functionalized Adenoviral Vectors Targeting G-Quadruplexes in the P1 Promoter of Bcl-2 Proto-Oncogene: A New Tool for Gene Modulation in Anticancer Therapy.
Falanga AP; Cerullo V; Marzano M; Feola S; Oliviero G; Piccialli G; Borbone N
Bioconjug Chem; 2019 Mar; 30(3):572-582. PubMed ID: 30620563
[TBL] [Abstract][Full Text] [Related]
2. Exploring the DNA
Falanga AP; Lupia A; Tripodi L; Morgillo CM; Moraca F; Roviello GN; Catalanotti B; Amato J; Pastore L; Cerullo V; D'Errico S; Piccialli G; Oliviero G; Borbone N
Heliyon; 2024 Feb; 10(3):e24599. PubMed ID: 38317891
[TBL] [Abstract][Full Text] [Related]
3. Targeted antisense radiotherapy and dose fractionation using a (177)Lu-labeled anti-bcl-2 peptide nucleic acid-peptide conjugate.
Liu D; Balkin ER; Jia F; Ruthengael VC; Smith CJ; Lewis MR
Nucl Med Biol; 2015 Sep; 42(9):704-10. PubMed ID: 26081917
[TBL] [Abstract][Full Text] [Related]
4. Quadruplex formation is necessary for stable PNA invasion into duplex DNA of BCL2 promoter region.
Onyshchenko MI; Gaynutdinov TI; Englund EA; Appella DH; Neumann RD; Panyutin IG
Nucleic Acids Res; 2011 Sep; 39(16):7114-23. PubMed ID: 21593130
[TBL] [Abstract][Full Text] [Related]
5. Copper-64-labeled anti-bcl-2 PNA-peptide conjugates selectively localize to bcl-2-positive tumors in mouse models of B-cell lymphoma.
Jia F; Balaji BS; Gallazzi F; Lewis MR
Nucl Med Biol; 2015 Nov; 42(11):809-15. PubMed ID: 26239085
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of radiometal-labeled and fluorescent cell-permeating peptide-PNA conjugates for targeting the bcl-2 proto-oncogene.
Gallazzi F; Wang Y; Jia F; Shenoy N; Landon LA; Hannink M; Lever SZ; Lewis MR
Bioconjug Chem; 2003; 14(6):1083-95. PubMed ID: 14624621
[TBL] [Abstract][Full Text] [Related]
7. In vitro transcriptional and translational block of the bcl-2 gene operated by peptide nucleic acid.
Mologni L; Nielsen PE; Gambacorti-Passerini C
Biochem Biophys Res Commun; 1999 Oct; 264(2):537-43. PubMed ID: 10529398
[TBL] [Abstract][Full Text] [Related]
8. Peptide-nucleic acids (PNAs): a tool for the development of gene expression modifiers.
Gambari R
Curr Pharm Des; 2001 Nov; 7(17):1839-62. PubMed ID: 11562312
[TBL] [Abstract][Full Text] [Related]
9. High-affinity homologous peptide nucleic acid probes for targeting a quadruplex-forming sequence from a MYC promoter element.
Roy S; Tanious FA; Wilson WD; Ly DH; Armitage BA
Biochemistry; 2007 Sep; 46(37):10433-43. PubMed ID: 17718513
[TBL] [Abstract][Full Text] [Related]
10. Intracellular delivery of antisense peptide nucleic acid by fluorescent mesoporous silica nanoparticles.
Ma X; Devi G; Qu Q; Toh DF; Chen G; Zhao Y
Bioconjug Chem; 2014 Aug; 25(8):1412-20. PubMed ID: 25055196
[TBL] [Abstract][Full Text] [Related]
11. Comparative biodistributions and dosimetry of [¹⁷⁷Lu]DOTA-anti-bcl-2-PNA-Tyr³-octreotate and [¹⁷⁷Lu]DOTA-Tyr³-octreotate in a mouse model of B-cell lymphoma/leukemia.
Balkin ER; Liu D; Jia F; Ruthengael VC; Shaffer SM; Miller WH; Lewis MR
Nucl Med Biol; 2014 Jan; 41(1):36-42. PubMed ID: 24267052
[TBL] [Abstract][Full Text] [Related]
12. Strand invasion of DNA quadruplexes by PNA: comparison of homologous and complementary hybridization.
Gupta A; Lee LL; Roy S; Tanious FA; Wilson WD; Ly DH; Armitage BA
Chembiochem; 2013 Aug; 14(12):1476-84. PubMed ID: 23868291
[TBL] [Abstract][Full Text] [Related]
13. G-rich sequence-specific recognition and scission of human genome by PNA/DNA hybrid G-quadruplex formation.
Ishizuka T; Yang J; Komiyama M; Xu Y
Angew Chem Int Ed Engl; 2012 Jul; 51(29):7198-202. PubMed ID: 22700182
[TBL] [Abstract][Full Text] [Related]
14. Peptide nucleic acids: on the road to new gene therapeutic drugs.
Nielsen PE
Pharmacol Toxicol; 2000 Jan; 86(1):3-7. PubMed ID: 10720100
[TBL] [Abstract][Full Text] [Related]
15. Stabilization of G-quadruplex in the BCL2 promoter region in double-stranded DNA by invading short PNAs.
Onyshchenko MI; Gaynutdinov TI; Englund EA; Appella DH; Neumann RD; Panyutin IG
Nucleic Acids Res; 2009 Dec; 37(22):7570-80. PubMed ID: 19820116
[TBL] [Abstract][Full Text] [Related]
16. Imaging endogenous gene expression in brain cancer in vivo with 111In-peptide nucleic acid antisense radiopharmaceuticals and brain drug-targeting technology.
Suzuki T; Wu D; Schlachetzki F; Li JY; Boado RJ; Pardridge WM
J Nucl Med; 2004 Oct; 45(10):1766-75. PubMed ID: 15471847
[TBL] [Abstract][Full Text] [Related]
17. Targeting Cancer Gene Dependencies with Anthrax-Mediated Delivery of Peptide Nucleic Acids.
Lu Z; Paolella BR; Truex NL; Loftis AR; Liao X; Rabideau AE; Brown MS; Busanovich J; Beroukhim R; Pentelute BL
ACS Chem Biol; 2020 Jun; 15(6):1358-1369. PubMed ID: 32348107
[TBL] [Abstract][Full Text] [Related]
18. Loop and backbone modifications of peptide nucleic acid improve g-quadruplex binding selectivity.
Lusvarghi S; Murphy CT; Roy S; Tanious FA; Sacui I; Wilson WD; Ly DH; Armitage BA
J Am Chem Soc; 2009 Dec; 131(51):18415-24. PubMed ID: 19947597
[TBL] [Abstract][Full Text] [Related]
19. Cellular delivery of peptide nucleic acid (PNA).
Koppelhus U; Nielsen PE
Adv Drug Deliv Rev; 2003 Feb; 55(2):267-80. PubMed ID: 12564980
[TBL] [Abstract][Full Text] [Related]
20. Targeting G-quadruplex structure in the human c-Kit promoter with short PNA sequences.
Amato J; Pagano B; Borbone N; Oliviero G; Gabelica V; Pauw ED; D'Errico S; Piccialli V; Varra M; Giancola C; Piccialli G; Mayol L
Bioconjug Chem; 2011 Apr; 22(4):654-63. PubMed ID: 21410246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
